Moleculin Biotech: Regulation FD disclosure and investor presentation

What happened Moleculin Biotech, Inc. filed a Form 8-K dated Oct 16, 2026 reporting a Regulation FD disclosure under Item 7.01 and stating that "the Company is using the attached presentation for its corporate presentation posted on the Company’s website and is set forth as Exhibit 99.1 herein."

Key details

• Item 7.01: Regulation FD disclosure was reported in the Form 8-K.
• Exhibit 99.1: Investor presentation dated Oct 16, 2026 is attached and posted on the company website.
• Item 9.01: The filing lists exhibits, including Exhibit 99.1 and an Inline XBRL cover page (Exhibit 104).

Why it may matter Item 7.01 covers Regulation FD disclosure, which documents the company’s public release of information via the attached investor presentation. Item 9.01 lists the exhibits filed with the report, including the presentation and the interactive data file. This filing does not show why the insider traded or why the company acted.